Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Biochemical Pharmacology|August 10, 2014
Smile--It's in your blood!Fulvio D'Acquisto, Lorenza Rattazzi, Giuseppa PirasBiochemical Pharmacology|February 26, 2013
Pro-inflammatory and pathogenic properties of Annexin-A1: the whole is greater than the sum of its partsFulvio D'Acquisto, Giuseppa Piras, Lorenza RattazziImmunology|June 20, 2014
'As above, so below' examining the interplay between emotion and the immune systemSamuel Brod, Lorenza Rattazzi, Giuseppa Piras, et al.Drug Discovery Today|July 2, 2014
Novel immunological targets in rheumatic diseases: clues from current therapiesFulvio D'Acquisto, Lorenza Rattazzi, Giuseppa Piras, et al.Frontiers in Immunology|December 7, 2013
Emotional change-associated T cell mobilization at the early stage of a mouse model of multiple sclerosisGiuseppa Piras, Lorenza Rattazzi, Adam McDermott, et al.Frontiers in Immunology|October 18, 2016
Impact of Enriched Environment on Murine T Cell Differentiation and Gene Expression ProfileLorenza Rattazzi, Giuseppa Piras, Samuel Brod, et al.Plos One|December 18, 2014
Formyl peptide receptor as a novel therapeutic target for anxiety-related disordersIrene Gallo, Lorenza Rattazzi, Giuseppa Piras, et al.Brain, Behavior, and Immunity|March 4, 2020
Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cellsGiuseppa Piras, Lorenza Rattazzi, Nikolaos Paschalidis, et al.Molecular Therapy. Methods & Clinical Development|August 11, 2020
Lentiviral Hematopoietic Stem Cell Gene Therapy Rescues Clinical Phenotypes in a Murine Model of Pompe DiseaseGiuseppa Piras, Claudia Montiel-Equihua, Yee-Ka Agnes Chan, et al.Human Gene Therapy|March 20, 2021
Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous DiseaseAndrea Schejtman, Winston Vetharoy, Uimook Choi, et al.Pageof 1